By: Kim Capstick
25 November 2010
Viruses can cause illnesses that range in severity from minor irritations to potentially fatal diseases – and have even been linked to the causes of some cancers.
Viral infections cause tremendous suffering worldwide, but can be effectively contained with the use of vaccines – which use genetic information from a virus to help immune systems recognize and target infection, and build resistance.
Pharmaceutical companies recognize the value of vaccines, and today GlaxoSmithKline (GSK) Canada has announced a $5-million research donation to the University of Alberta’s Institute for Viral Immunology.
Read the entire article here.